PANTHER

United Kingdom
|
2024
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Baricitinib
  • Simvastatin
  • Immnunomodulator

ECRAID-REMAP-CAP

Belgium Croatia Czech Republic Estonia France Germany Hungary Ireland Italy The Netherlands Portugal Serbia Slovenia Spain Switzerland United Kingdom
|
2018
  • Adults
  • Paediatric
  • Hospital wide
  • Intensive care unit
  • Influenza A(H5N1) virus
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Post-COVID-19
  • Avian Influenza
  • Flu
  • Pharmacological intervention
  • Oseltamivir
  • Baloxavir
  • Corticosteroid
  • Immnunomodulator
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immnunomodulator
  • Antineoplastic agent
  • Imatinib
  • Infliximab
  • Monoclonal antibodies

Wildi

Argentina Australia Brazil Germany Hong Kong Italy Japan South Africa Spain United States of America Ireland
|
2020
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample

PHOSP-COVID

United Kingdom
|
2020
  • Adults
  • Elderly
  • General population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

López-González

Spain
|
2021
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

LUNGTERMcov

Switzerland
|
2021-2023
  • Adults
  • Elderly
  • General population
  • Hospital wide
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

COVIXTREM

Spain
|
2022-2022
  • Adults
  • Paediatric
  • Elderly
  • General population
  • Hospital wide
  • Outpatient clinic
  • Intensive care unit
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Blood sample